Patents by Inventor J. Martin Grisar
J. Martin Grisar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 5721233Abstract: Derivatives of 2,3-dihydro-5-benzofuranol, intermediates thereof, and processes useful for their preparation. These compounds are free radical scavengers and are useful in the treatment of conditions capable of being treated by free radical scavengers, such as stroke, nervous system trauma and reperfusion damage.Type: GrantFiled: December 22, 1994Date of Patent: February 24, 1998Assignee: Merrell Pharmaceuticals Inc.Inventors: J. Martin Grisar, Margaret A. Petty, Frank Bolkenius
-
Patent number: 5545660Abstract: This invention relates to novel hydrazide acyl hydrazinium derivatives of certain 3,4-dihydro-2H-1-benzopyrans of the formula ##STR1## the stereoisomers and mixtures thereof, their inner salts, and the pharmaceutically acceptable salts thereof whereinR is H or C.sub.1-6 alkyl,R.sub.1 is C.sub.1-6 alkyl,R.sub.2 is H or --C(O)R,R.sub.3 and R.sub.4 are independently C.sub.1-6 alkyl;R.sub.5 is C.sub.1-6 alkyl, or ##STR2## with R.sub.8 being H or halogeno, n is zero, 1, 2, or 3 andis a halide, --S(O).sub.3 R.sub.6, or nothing when the inner salt is formedR.sub.6 is H, C.sub.1-6 alkyl, phenyl or 4-methylphenyl,to the intermediates, processes and techniques for their preparation, to their ability to manifest the property of being free radical scavengers, and to their end-use application in the treatment of disease conditions capable of being ameliorated by free radical scavengers.Type: GrantFiled: October 6, 1994Date of Patent: August 13, 1996Assignee: Merrell Pharmaceuticals Inc.Inventors: J. Martin Grisar, Margaret A. Petty, Frank Bolkenius
-
Patent number: 5510373Abstract: This invention relates to certain hydroxy derivatives of 3,4-dihydro-2,5,7,8-tetraalkyl-2H-1-benzopyran-2-carboxylic acids and the lactones thereof, to the processes and intermediates useful for their preparation and to their use as free radical scavengers useful in the treatment of tissue damage implicated with free oxygen radicals.Type: GrantFiled: October 5, 1994Date of Patent: April 23, 1996Assignee: Merrell Pharmaceuticals Inc.Inventors: J. Martin Grisar, Margaret A. Petty, Frank Bolkenius
-
Patent number: 5500444Abstract: This invention relates to quaternary ammonium salts of certain 2H-1-benzopyran derivatives, to the intermediates and processes useful for their preparation, to their free-radical scavenger and cellular protective properties and to their end-use application as therapeutic agents.Type: GrantFiled: September 27, 1994Date of Patent: March 19, 1996Assignee: Hoechst Marion Roussel, Inc.Inventors: J. Martin Grisar, Margaret A. Petty, Frank Bolkenius
-
Patent number: 5484810Abstract: This invention relates to alkylated sulfonium alkylene derivatives of certain 2H-1-benzopyrans, to the intermediates and processes useful for their preparation, to their free-radical scavenger and cardioprotective properties and to their end-use application as therapeutic agents.Type: GrantFiled: February 28, 1995Date of Patent: January 16, 1996Assignee: Merrell Dow Pharmaceuticals Inc.Inventors: J. Martin Grisar, Margaret A. Petty, Frank Bolkenius
-
Patent number: 5270336Abstract: Derivatives of 3,4-dihydroxy-2,5-dihydrofuran-5-ones, intermediates and processes useful for their preparation are disclosed. These compounds are useful as free-radical scavengers and exhibit cellular protective properties.Type: GrantFiled: August 26, 1992Date of Patent: December 14, 1993Assignee: Merrell Dow Pharmaceuticals Inc.Inventors: Gilbert Marciniak, J. Martin Grisar
-
Patent number: 5175188Abstract: Derivatives of 3,4-dihydroxy-2,5-dihydrofuran-5-ones, intermediates and processes useful for their preparation are disclosed. These compounds are useful as free-radical scavengers and exhibit cellular protective properties.Type: GrantFiled: January 10, 1992Date of Patent: December 29, 1992Assignee: Merrell Dow Pharmaceuticals Inc.Inventors: Gilbert Marciniak, J. Martin Grisar
-
Patent number: 4927939Abstract: Aroylthiazolones enhance myocardial contractile force and are useful as cardiotonics in the treatment of heart failure.Type: GrantFiled: March 17, 1987Date of Patent: May 22, 1990Assignee: Merrell Dow PharmaceuticalsInventors: J. Martin Grisar, Richard C. Dage, Richard A. Schnettler
-
Patent number: 4868197Abstract: A sulfur analog of enoximone, 1,3-dihydro-4-methyl-5-[4-(methylthio)benzoyl]-2H-imidazol-2-thione, is reported to reduce reperfusion injury, the injry which occurs when molecular oxygen is reintroduced into an ischemic tissue. The compound could be used to prevent much of the damage which occurs to the heart of a heart attack victim.Type: GrantFiled: March 21, 1988Date of Patent: September 19, 1989Assignee: Merrell Dow Pharmaceuticals Inc.Inventors: Richard A. Schnettler, Richard C. Dage, J. Martin Grisar, Frank P. Palopoli
-
Patent number: 4762849Abstract: Novel alkanoylthiazolones enhance myocardial contractile force and are useful as cardiotonics in the treatment of heart failure.Type: GrantFiled: October 15, 1985Date of Patent: August 9, 1988Assignee: Merrell Dow Pharmaceuticals Inc.Inventors: J. Martin Grisar, Richard C. Dage, Richard A. Schnettler
-
Patent number: 4734422Abstract: Aroylthiazolones enhance myocardial contractile force and are useful as cardiotonics in the treatment of heart failure.Type: GrantFiled: February 26, 1987Date of Patent: March 29, 1988Assignee: Merrell Dow Pharmaceuticals Inc.Inventors: J. Martin Grisar, Richard C. Dage, Richard A. Schnettler
-
Patent number: 4623651Abstract: Heterocyclocarbonyl- and acetyl-thiazolones enhance myocardial contractile force and are useful as cardiotonics in the treatment of heart failure.Type: GrantFiled: October 15, 1985Date of Patent: November 18, 1986Assignee: Merrell Dow Pharmaceuticals Inc.Inventors: J. Martin Grisar, Richard C. Dage, Richard A. Schnettler
-
Patent number: 4560700Abstract: Pyrrole-3-carboxylates of the following general structure ##STR1## wherein R.sub.1 is a hydrogen or lower alkyl group; R.sub.2 is a 1 to 8 carbon atom alkyl group; and R.sub.3 is a hydrogen, lower alkyl, pyridyl, pyridylmethyl, pyrryl, pyrrylmethyl, thienyl, thienylmethyl or phenyl or benzyl optionally substituted with one or two lower alkyl, lower alkoxy, lower alkylthio, halogen, nitro, hydroxy, carboxy or cyano groups or with a methylenedioxy group.Type: GrantFiled: February 8, 1985Date of Patent: December 24, 1985Assignee: Merrell Dow Pharmaceuticals Inc.Inventors: Richard A. Schnettler, Richard C. Dage, J. Martin Grisar
-
Patent number: 4526981Abstract: 1,3-Dihydro-2H-imidazol-2-ones having 5-acyl and 4-oxymethyl substituents, are useful as cardiotonics, antihypertensives and antithrombotic agents. The compounds are obtained by the reaction of an appropriate alcohol or a silver salt with a substituted 4-bromomethyl-1,3-dihydro-2H-imidazol-2-one.Type: GrantFiled: April 29, 1983Date of Patent: July 2, 1985Assignee: Merrell Dow Pharmaceuticals Inc.Inventors: J. Martin Grisar, Richard A. Schnettler, Richard C. Dage
-
Patent number: 4447619Abstract: 4-alkanoylimidazol-2-ones of the following general structure which are useful as cardiotonics in the treatment of cardiac failure ##STR1## wherein Q and T are each an oxygen atom or a divalent sulfur atom; R is hydrogen, lower alkyl, lower alkylcarbonyl or benzoyl; R.sub.1 is hydrogen or lower alkyl; R.sub.2 is a lower aliphatic hydrocarbon radical, phenyl alkylene or heterocyclo alkylene; and the pharmaceutically acceptable salts thereof.Type: GrantFiled: September 27, 1982Date of Patent: May 8, 1984Assignee: Merrell Dow Pharmaceuticals Inc.Inventors: J. Martin Grisar, Richard A. Schnettler, Richard C. Dage
-
Patent number: 4418071Abstract: The use of novel imidazolecarboxylic acid derivatives of the following general structure which are useful as antihypertensives, cardiotonics and antithrombotics ##STR1## wherein Q and T are an oxygen or sulfur atom; R is hydrogen, lower alkyl, lower alkylcarbonyl or benzoyl; R.sub.1 is hydrogen or --CH(R.sub.3)R.sub.4 ; R2 is lower alkoxy, phenoxy or phenoxy substituted at the ortho, meta, or para position with lower alkyl, lower alkoxy, hydroxy, halogen, trifluoromethyl, lower alkylthio, lower alkylsulfone, or lower alkylsulfoxide; R.sub.3 is hydrogen or lower alkyl; R.sub.4 is hydrogen, hydroxy, lower alkoxy, lower alkylcarbonyl, --ONO.sub.2 or halogen; and their pharmaceutically acceptable salts thereof.Type: GrantFiled: November 4, 1981Date of Patent: November 29, 1983Assignee: Merrell Dow Pharmaceuticals Inc.Inventors: Richard A. Schnettler, Richard C. Dage, J. Martin Grisar
-
Patent number: 4410540Abstract: This invention relates to aroyl-2-imidazolidinones of the following general structure which are useful as cardiotonics and antihypertensive agents ##STR1## wherein Ar is furanyl, thienyl, 1H-pyrrolyl, or phenyl optionally substituted with one or two X groups; X is halogen, hydroxy, lower alkyl, lower alkoxy, lower alkylthio, lower alkylsulfoxide, lower alkylsulphone, trifluoromethyl, --SO.sub.2 N(R.sub.2).sub.2, NR.sub.3 R.sub.4, pyrrolidino, piperidino, morpholino, piperazino or N'-alkyl-piperazino; R is hydrogen, lower alkyl, lower alkylcarbonyl or benzoyl; each of R.sub.1, R.sub.2, R.sub.3 and R.sub.4 is hydrogen or lower alkyl; T is an oxygen atom or a divalent sulfur atom; and the pharmaceutically acceptable salts thereof.Type: GrantFiled: November 4, 1981Date of Patent: October 18, 1983Assignee: Merrell Dow Pharmaceuticals Inc.Inventors: Richard A. Schnettler, Richard C. Dage, J. Martin Grisar
-
Patent number: 4405628Abstract: This invention relates to aroylimidazole-2-ones and their acid and base addition salts as well as their use as cardiotonics in the treatment of cardiac failure.Type: GrantFiled: October 23, 1981Date of Patent: September 20, 1983Assignee: Merrell Dow Pharmaceuticals Inc.Inventors: Richard C. Dage, Frank P. Palopoli, Richard A. Schnettler, J. Martin Grisar
-
Patent number: 4381393Abstract: 1,3-Dihydro-2H-imidazol-2-ones having 5-acyl and 4-(substituted amino)methyl substituents, are useful as cardiotonics, antihypertensives and antithrombotic agents. The compounds are obtained by the reaction of an appropriate amine with a substituted 4-bromomethyl-1,3-dihydro-2H-imidazol-2-one.Type: GrantFiled: May 4, 1981Date of Patent: April 26, 1983Assignee: Merrell Dow Pharmaceuticals Inc.Inventors: J. Martin Grisar, Richard A. Schnettler, Richard C. Dage
-
Patent number: 4371737Abstract: 2,3-Dihydro-2-oxo-1H-imidazole-4-carboxylic acid derivatives having a (substituted amino)methyl substituent at the 5-position, are useful as cardiotonics, antihypertensives and antithrombotic agents. The compounds are obtained by the reaction of an appropriate amine with a 5-(bromomethyl)-2,3-dihydro-2-oxo-1H-imidazole-4-carboxylic acid ester or amide.Type: GrantFiled: May 4, 1981Date of Patent: February 1, 1983Assignee: Merrell Dow Pharmaceuticals Inc.Inventors: J. Martin Grisar, Richard A. Schnettler, Richard C. Dage